Seroprevalence of human granulocytic anaplasmosis in Berlin/Brandenburg, Germany: An 8-year survey

Clinical Microbiology and Infection

Volumn 12, Issue 9, 2006, Pages 924-927

  Kowalski, J ^a   Hopfenmuller W ^a   Fingerle, V ^b   Malberg, H ^c   Eisenblatter M ^a   Wagner, J ^a   Miksits, K ^a   Hahn, H ^a   Ignatius, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Anaplasma phagocytophilum; Annual distribution; Diagnosis; Human granulocytic anaplasmosis; Seroprevalence; Tick borne disease

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GERMANY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; TICK BITE; TICK BORNE DISEASE;

ACARI; ANAPLASMA PHAGOCYTOPHILUM; BORRELIA; BORRELIA BURGDORFERI;

EID: 33746602322     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01490.x     Document Type: Article

References (20)

1. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect 2002; 8: 763-772.
2. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet Res 2005; 36: 469-492.
3. Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004; 10: 1108-1132.
4. Fingerle V, Goodman JL, Johnson RC, Kurtti TJ, Munderloh UG, Wilske B. Human granulocytic ehrlichiosis in southern Germany: Increased seroprevalence in high-risk groups. J Clin Microbiol 1997; 35: 3244-3247.
5. Hunfeld KP, Brade V. Prevalence of antibodies against the human granulocytic ehrlichiosis agent in Lyme borreliosis patients from Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 221-224.
6. Woessner R, Gaertner BC, Grauer MT et al. Incidence and prevalence of infection with human granulocytic ehrlichiosis agent in Germany. A prospective study in young healthy subjects. Infection 2001; 29: 271-273.
7. Matuschka FR, Heiler M, Eiffert H, Fischer P, Lotter H, Spielman A. Diversionary role of hoofed game in transmission of Lyme disease spirochetes. Am J Trop Med Hyg 1993; 48: 693-699.
8. Guillaume B, Heyman P, Lafontaine S, Vandenvelde C, Delmee M, Bigaignon G. Seroprevalence of human granulocytic ehrlichiosis infection in Belgium. Eur J Clin Microbiol Infect Dis 2002; 21: 397-400.
9. Groen J, Koraka P, Nur YA et al. Serologic evidence of ehrlichiosis among humans and wild animals in The Netherlands. Eur J Clin Microbiol Infect Dis 2002; 21: 46-49.
10. Lebech AM, Hansen K, Pancholi P, Sloan LM, Magera JM, Persing DH. Immunoserologic evidence of human granulocytic ehrlichiosis in Danish patients with Lyme neuroborreliosis. Scand J Infect Dis 1998; 30: 173-176.
11. Oteo JA, Gil H, Barral M et al. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol Infect 2001; 127: 353-358.
12. Unver A, Felek S, Paddock CD et al. Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. J Clin Microbiol 2001; 39: 3982-3986.
13. Barbet AF, Meeus PF, Belanger M et al. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun 2003; 71: 1706-1718.
14. Anonymous. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997; 46: 1-55.
15. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000; 31: 554-560.
16. Lotric-Furlan S, Avsic-Zupanc T, Petrovec M et al. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Laboratory Immunol 2001; 8: 899-903.
17. Githeko AK, Lindsay SW, Confalonieri UE, Patz JA. Climate change and vector-borne diseases: A regional analysis. Bull WHO 2000; 78: 1136-1147.
18. Levin ML, des Vignes F, Fish D. Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. Emerg Infect Dis 1999; 5: 204-208.
19. Levin ML, Fish D. Immunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila. Infect Immun 2000; 68: 1514-1518.
20. Bown KJ, Begon M, Bennett M, Woldehiwet Z, Ogden NH. Seasonal dynamics of Anaplasma phagocytophila in a rodent-tick (Ixodes trianguliceps) system, United Kingdom. Emerg Infect Dis 2003; 9: 63-70.